Skip to main content

Govt building

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure access Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Clinical and Experimental Effects of Reserpine in Patients with Essential Hypertension

 Digital Record
Identifier: 101584929X45
Digital Object (text)

Go to file

Dates

  • Publication: 30 April 1954

Extent

9 pages

Creator

Description

In this article, Freis and Ari presented the clinical data on their research for the ganglionic-blocking agent reserpine. They determined that it was ideal for treatment of mild hypertension, but because of its additive qualities, could be used in conjunction with other antihypertensive agents, such as hydralazine, for more severe cases.

Language of Materials

English

Additional Description

Original Profiles System Identifier

XFBBDD

Source Category

Periodical

Freis, Edward D., and Recep Ari. "Clinical and Experimental Effects of Reserpine in Patients with Essential Hypertension." Annals of the New York Academy of Sciences 59, (30 April 1954): 45-53. Article. 9 Images.

Annals of the New York Academy of Sciences

Physical Description

Physical Condition - Good

Photocopy Only

Subjects

Related Names

Creator

Linked Records

Collecting Area Details

Collecting Area Details

Part of the Archives and Modern Manuscripts Collections Collecting Area

Contact:
8600 Rockville Pike
Bldg 38/1E-21, MSC 3819
Bethesda MD 20894 US
1-888-FINDNLM (1-888-346-3656)